Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
2,343,772
-
Shares change
-
+2,309,497
-
Total reported value, excl. options
-
$21,986,514
-
Value change
-
+$21,240,741
-
Put/Call ratio
-
36.4%
-
Number of buys
-
44
-
Price
-
$9.2
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q1 2021
56 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2021.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,343,772 shares
of 56,066,823 outstanding shares and own 4.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (817,805 shares), MILLENNIUM MANAGEMENT LLC (212,650 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (197,059 shares), GEODE CAPITAL MANAGEMENT, LLC (177,980 shares), JANE STREET GROUP, LLC (159,745 shares), CITADEL ADVISORS LLC (157,471 shares), Tower Research Capital LLC (TRC) (64,985 shares), BlackRock Inc. (58,883 shares), Arete Wealth Advisors, LLC (52,844 shares), and Virtu Financial LLC (38,196 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.